Back to search

IVIg in the treatment of patients with factor VIII inhibitors

Data up to Jan 2025

Published1995
Citations1
References12

Total Citations Per Year

Abstract

References (12)

HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD

1981 • 1,659 citations

ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN

1984 • 485 citations

Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura

1983 • 299 citations

Identification by HLA Typing of Intrauterine-Derived Maternal T Cells in Four Patients with Severe Combined Immunodeficiency

1982 • 249 citations

Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.

1987 • 156 citations

Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals.

1992 • 141 citations

Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.

1988 • 118 citations

Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg)

1992 • 85 citations

Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulin

1984 • 33 citations

An Acquired Factor VIII Inhibitor Responsive to High-Dose Gamma Globulin

1987 • 31 citations

Development of anti‐idiotypic antibodies in a patient with a factor VIII autoantibody

1989 • 19 citations

Autoimmune Factor VIII Inhibitor Responsive to Gammaglobulin without In Vitro Neutralisation

1988 • 11 citations

Cited By (0)

Loading...